Biopsy-guided pathological response assessment in breast cancer is insufficient: additional pathology findings of the micra trial

HIGHLIGHTS

  • who: Annemiek K. E. van Hemert from the DepartmentAmsterdam University The Netherlands have published the research: Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial, in the Journal: (JOURNAL)
  • what: In this study, the pathology results of biopsies obtained after NST and of the surgical specimen of 167 patients participating in the MICRA trial (NTR6120) were examined and analyzed. The results of this study show that only limited residual invasive disease is present in patients with a favorable response on MRI.

SUMMARY

    (HR . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?